With 0.58 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.75 million shares. During the session, the Medical Instruments & Supplies company that operates in wider Healthcare sector, reached to the highest price of $34.82 whereas the lowest price it dropped to was $32.73. The 52-week range on STAA shows that it touched its highest point at $73.13 and its lowest point at $26.66 during that stretch. It currently has a 1-year price target of $40.88. Beta for the stock currently stands at 0.84.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of STAA was up-trending over the past week, with a rise of 1.84%, but this was up by 19.63% over a month. Three-month performance surged to 0.88% while six-month performance fell -22.71%. The stock lost -44.48% in the past year, while it has gained 6.63% so far this year. A look at the trailing 12-month EPS for STAA yields 0.43 with Next year EPS estimates of 0.89. For the next quarter, that number is 0.02. This implies an EPS growth rate of -47.87% for this year and 68.44% for next year. EPS is expected to grow by 30.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 31.51%.
Float and Shares Shorts:
At present, 48.84 million STAA shares are outstanding with a float of 48.35 million shares on hand for trading. On Feb 15, 2024, short shares totaled 6.45 million, which was 13.20% higher than short shares on Jan 12, 2024. In addition to STLA as the firm’s Stellantis N.V., STAA serves as its STAAR Surgical Company.
Institutional Ownership:
Through their ownership of 107.64% of STAA’s outstanding shares, institutional investors have majority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for STAA since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
Dividends & Yield:
In terms of dividends, STAA has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and STAA currently yields $0.00. In the past year, STAA’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, STAA has a current buyback yield of $0.12. This was $0.12 for the TTM, and it was $– for the past five years.
Summary of Insider Activity:
Insiders traded STAA stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 62 while that of sell transactions has risen to 18 over the past year. The total number of shares bought during that period was 1,418,046 while 14,977 shares were sold.
